DUSP26 and neuroblastoma: Having shown that nanomolar doses of NSC-87877 can result in a proliferation defect in NB cell lines similar to shRNA knockdown of DUSP26, we tested higher doses of NSC-87877 on NB to see if cytotoxicity could be induced.